SMC expands with end-to-end fill/finish facility in Charlotte, N.C.

并购
NEWS RELEASE: SMC Ltd. Announces Expansion of Sterile Fill Finish Capabilities, Unveiling State-of-the-Art Facility in North Carolina. Somerset, Wisconsin — SMC Ltd., the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility in Charlotte, North Carolina. The facility enables SMC to offer a wider portfolio of services to its pharma clients including lab-to-market development, analytical services, device manufacture, fill/finish, final assembly, and secondary packaging. The state-of-the-art facility compliments SMC’s footprint of global manufacturing capabilities and illustrates SMC’s commitment to the pharma services industry by offering high-speed, sterile fill finish lines with onsite formulation, compounding, and packaging capabilities. VP and General Manager, Uri Baruch commented, “There are notable developments in the injectables market – the growth of more complex biologics and the increased interest in delivering large volumes of API. We believe our ability to deliver, at speed, fill volumes from 1ml to 50ml is an unmet need and is already attracting significant attention from our clients and partners.” “SMC is recognized globally for its ability to deliver complex, complete drug delivery systems with unrivalled speed and agility. This acquisition not only adds to this capability, it reaffirms our commitment to the pharma market and completes another phase of our growth agenda.” “At SMC, we have a proud 36-year history of innovating for contract manufacturing and pharma services customers,” said Chetan Patel, SMC Ltd.’s CEO. “This new North Carolina facility is another example of SMC adding the expertise, capabilities, and capacity our customers need to be successful. We know North Carolina’s fill finish capabilities will allow SMC and our pharmaceutical customers to form deeper partnerships well into the future.” The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。